{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:27:26Z","timestamp":1767598046159},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T00:00:00Z","timestamp":1284508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00277-010-1066-2","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T15:25:45Z","timestamp":1284477945000},"page":"1185-1195","source":"Crossref","is-referenced-by-count":22,"title":["Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate"],"prefix":"10.1007","volume":"89","author":[{"given":"Roberto","family":"Stasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Newland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,15]]},"reference":[{"issue":"4","key":"1066_CR1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","volume":"120","author":"British Committee for Standards in Haematology General Haematology Task Force","year":"2003","unstructured":"British Committee for Standards in Haematology General Haematology Task Force (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120(4):574\u2013596","journal-title":"Br J Haematol"},{"issue":"1","key":"1066_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","volume":"88","author":"JN George","year":"1996","unstructured":"George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88(1):3\u201340","journal-title":"Blood"},{"issue":"2","key":"1066_CR3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB et al (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115(2):168\u2013186","journal-title":"Blood"},{"issue":"3 Suppl 5","key":"1066_CR4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminhematol.2006.04.009","volume":"43","author":"J Bussel","year":"2006","unstructured":"Bussel J (2006) Treatment of immune thrombocytopenic purpura in adults. Semin Hematol 43(3 Suppl 5):S3\u2013S10, discussion S8\u20139","journal-title":"Semin Hematol"},{"key":"1066_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.med.56.082103.104644","volume":"56","author":"DB Cines","year":"2005","unstructured":"Cines DB, McMillan R (2005) Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 56:425\u2013442","journal-title":"Annu Rev Med"},{"issue":"5","key":"1066_CR6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","volume":"98","author":"R Stasi","year":"1995","unstructured":"Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F et al (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 98(5):436\u2013442","journal-title":"Am J Med"},{"issue":"8","key":"1066_CR7","first-page":"1041","volume":"91","author":"T Sailer","year":"2006","unstructured":"Sailer T, Lechner K, Panzer S, Kyrle PA, Pabinger I (2006) The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy. Haematologica 91(8):1041\u20131045","journal-title":"Haematologica"},{"key":"1066_CR8","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura (ITP) of adults and children: report from an international working group. Blood 113:2386\u20132393","journal-title":"Blood"},{"issue":"2","key":"1066_CR9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00000658-192308000-00009","volume":"78","author":"JM Hitzrot","year":"1923","unstructured":"Hitzrot JM (1923) Splenectomy in hemorrhagic purpura: idiopathic purpura, essential thrombopenie (Frank). Purpura hemorrhagic protopathique (Hayem). Ann Surg 78(2):185\u2013190","journal-title":"Ann Surg"},{"issue":"9","key":"1066_CR10","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","volume":"104","author":"K Kojouri","year":"2004","unstructured":"Kojouri K, Vesely SK, Terrell DR, George JN (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 104(9):2623\u20132634","journal-title":"Blood"},{"issue":"9","key":"1066_CR11","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","volume":"97","author":"JE Portielje","year":"2001","unstructured":"Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97(9):2549\u20132554","journal-title":"Blood"},{"issue":"2","key":"1066_CR12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.10253","volume":"72","author":"J Schwartz","year":"2003","unstructured":"Schwartz J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB (2003) Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol 72(2):94\u201398","journal-title":"Am J Hematol"},{"issue":"4","key":"1066_CR13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000204523","volume":"89","author":"A Naouri","year":"1993","unstructured":"Naouri A, Feghali B, Chabal J, Boulez J, Dechavanne M, Viala JJ et al (1993) Results of splenectomy for idiopathic thrombocytopenic purpura. Review of 72 cases. Acta Haematol 89(4):200\u2013203","journal-title":"Acta Haematol"},{"issue":"1","key":"1066_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V77.1.31.31","volume":"77","author":"S Cortelazzo","year":"1991","unstructured":"Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T (1991) High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 77(1):31\u201333","journal-title":"Blood"},{"issue":"4","key":"1066_CR15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0039-6060(03)00312-X","volume":"134","author":"ER Winslow","year":"2003","unstructured":"Winslow ER, Brunt LM (2003) Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery 134(4):647\u2013653, discussion 54\u20135","journal-title":"Surgery"},{"issue":"14","key":"1066_CR16","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","volume":"114","author":"SE Crary","year":"2009","unstructured":"Crary SE, Buchanan GR (2009) Vascular complications after splenectomy for hematologic disorders. Blood 114(14):2861\u20132868","journal-title":"Blood"},{"issue":"1","key":"1066_CR17","first-page":"72","volume":"90","author":"N Vianelli","year":"2005","unstructured":"Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG et al (2005) Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 90(1):72\u201377","journal-title":"Haematologica"},{"issue":"1 Suppl 1","key":"1066_CR18","first-page":"22","volume":"37","author":"WR Bell Jr","year":"2000","unstructured":"Bell WR Jr (2000) Long-term outcome of splenectomy for idiopathic thrombocytopenic purpura. Semin Hematol 37(1 Suppl 1):22\u201325","journal-title":"Semin Hematol"},{"issue":"3","key":"1066_CR19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2141.1997.832723.x","volume":"97","author":"Y Najean","year":"1997","unstructured":"Najean Y, Rain JD, Billotey C (1997) The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol 97(3):547\u2013550","journal-title":"Br J Haematol"},{"issue":"21","key":"1066_CR20","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199705223362104","volume":"336","author":"C Law","year":"1997","unstructured":"Law C, Marcaccio M, Tam P, Heddle N, Kelton JG (1997) High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 336(21):1494\u20131498","journal-title":"N Engl J Med"},{"issue":"1","key":"1066_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajh.1072","volume":"67","author":"JB Bussel","year":"2001","unstructured":"Bussel JB, Kaufmann CP, Ware RE, Woloski BM (2001) Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Am J Hematol 67(1):27\u201333","journal-title":"Am J Hematol"},{"issue":"1","key":"1066_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1054\/blre.2001.0180","volume":"16","author":"WR Bell Jr","year":"2002","unstructured":"Bell WR Jr (2002) Role of splenectomy in immune (idiopathic) thrombocytopenic purpura. Blood Rev 16(1):39\u201341","journal-title":"Blood Rev"},{"issue":"8","key":"1066_CR23","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/j.1538-7836.2006.02013.x","volume":"4","author":"JN George","year":"2006","unstructured":"George JN (2006) Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 4(8):1664\u20131672","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1066_CR24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1182\/blood-2003-11-3908","volume":"104","author":"R McMillan","year":"2004","unstructured":"McMillan R, Durette C (2004) Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood 104(4):956\u2013960","journal-title":"Blood"},{"issue":"3","key":"1066_CR25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2008.07464.x","volume":"144","author":"JN George","year":"2009","unstructured":"George JN, Mathias SD, Go RS, Guo M, Henry DH, Lyons R et al (2009) Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol 144(3):409\u2013415","journal-title":"Br J Haematol"},{"issue":"5","key":"1066_CR26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","volume":"2","author":"JM Davies","year":"2002","unstructured":"Davies JM, Barnes R, Milligan D (2002) Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clinical Medicine 2(5):440\u2013443, London, England","journal-title":"Clinical Medicine"},{"issue":"6921","key":"1066_CR27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.308.6921.131b","volume":"308","author":"M Makris","year":"1994","unstructured":"Makris M, Greaves M, Winfield DA, Preston FE, Lilleyman JS (1994) Long-term management after splenectomy. Lifelong penicillin unproved in trials. BMJ 308(6921):131\u2013132, Clinical research ed","journal-title":"BMJ"},{"issue":"1","key":"1066_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.thj.6200328","volume":"5","author":"MS El-Alfy","year":"2004","unstructured":"El-Alfy MS, El-Sayed MH (2004) Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention? Hematol J 5(1):77\u201380","journal-title":"Hematol J"},{"issue":"2","key":"1066_CR29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.21109","volume":"83","author":"F Rodeghiero","year":"2008","unstructured":"Rodeghiero F, Ruggeri M (2008) Is splenectomy still the gold standard for the treatment of chronic ITP? Am J Hematol 83(2):91","journal-title":"Am J Hematol"},{"issue":"3","key":"1066_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/BOR.0b013e3282f5e08d","volume":"20","author":"T Dorner","year":"2008","unstructured":"Dorner T, Burmester GR (2008) New approaches of B-cell-directed therapy: beyond rituximab. Curr Opin Rheumatol 20(3):263\u2013268","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"1066_CR31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0037-1963(00)90107-0","volume":"37","author":"JN George","year":"2000","unstructured":"George JN, Kojouri K, Perdue JJ, Vesely SK (2000) Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol 37(3):290\u2013298","journal-title":"Semin Hematol"},{"issue":"1","key":"1066_CR32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2141.1974.tb06780.x","volume":"27","author":"I Branehog","year":"1974","unstructured":"Branehog I, Kutti J, Weinfeld A (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). Br J Haematol 27(1):127\u2013143","journal-title":"Br J Haematol"},{"issue":"1","key":"1066_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0609.1974.tb00182.x","volume":"12","author":"I Branehog","year":"1974","unstructured":"Branehog I, Weinfeld A (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP) before and during treatment with corticosteroids. Scand J Haematol 12(1):69\u201379","journal-title":"Scand J Haematol"},{"issue":"9610","key":"1066_CR34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","volume":"371","author":"DJ Kuter","year":"2008","unstructured":"Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM et al (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 371(9610):395\u2013403","journal-title":"Lancet"},{"issue":"3","key":"1066_CR35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00296-007-0471-x","volume":"28","author":"DG Arkfeld","year":"2008","unstructured":"Arkfeld DG (2008) The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int 28(3):205\u2013215","journal-title":"Rheumatol Int"},{"issue":"2","key":"1066_CR36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419","volume":"86","author":"K Kaushansky","year":"1995","unstructured":"Kaushansky K (1995) Thrombopoietin: the primary regulator of platelet production. Blood 86(2):419\u2013431","journal-title":"Blood"},{"issue":"6","key":"1066_CR37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.clpt.2004.08.010","volume":"76","author":"B Wang","year":"2004","unstructured":"Wang B, Nichol JL, Sullivan JT (2004) Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin Pharmacol Ther 76(6):628\u2013638","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1066_CR38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.2006.06339.x","volume":"135","author":"A Newland","year":"2006","unstructured":"Newland A, Caulier MT, Kappers-Klunne M, Schipperus MR, Lefrere F, Zwaginga JJ et al (2006) An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura. Br J Haematol 135(4):547\u2013553","journal-title":"Br J Haematol"},{"issue":"16","key":"1066_CR39","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa054626","volume":"355","author":"JB Bussel","year":"2006","unstructured":"Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT et al (2006) AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 355(16):1672\u20131681","journal-title":"N Engl J Med"},{"issue":"7","key":"1066_CR40","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V99.7.2599","volume":"99","author":"RL Basser","year":"2002","unstructured":"Basser RL, O'Flaherty E, Green M, Edmonds M, Nichol J, Menchaca DM et al (2002) Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 99(7):2599\u20132602","journal-title":"Blood"},{"issue":"12","key":"1066_CR41","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","volume":"98","author":"J Li","year":"2001","unstructured":"Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M et al (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98(12):3241\u20133248","journal-title":"Blood"},{"key":"1066_CR42","unstructured":"Nplate\u00ae Summary of Product Characteristics. Available at: http:\/\/www.ema.europa.eu\/humandocs\/PDFs\/EPAR\/nplate\/emea-combined-h942en.pdf . Last accessed 21 Apr 2010"},{"issue":"10","key":"1066_CR43","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood-2008-04-150078","volume":"113","author":"JB Bussel","year":"2009","unstructured":"Bussel JB, Kuter DJ, Pullarkat V, Lyons RM, Guo M, Nichol JL (2009) Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood 113(10):2161\u20132171, Erratum in: Blood. 2009;113:4822","journal-title":"Blood"},{"issue":"22","key":"1066_CR44","first-page":"681","volume":"114","author":"JB Bussel","year":"2009","unstructured":"Bussel JB, Kuter DJ, Newland A, de Wolf JTM, Wasser J, Chang P et al (2009) Long-term efficacy and safety of romiplostim for the treatment of patients with chronic immune thrombocytopenia (ITP): 5-year update from an open-label extension study. ASH 114(22):681, Annual Meeting Abstracts","journal-title":"ASH"},{"issue":"6","key":"1066_CR45","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1538-7836.2010.03830.x","volume":"8","author":"TB Gernsheimer","year":"2010","unstructured":"Gernsheimer TB, George JN, Aledort LM, Tarantino MD, Sunkara U, Matthew Guo D, Nichol JL (2010) Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with Chronic Immune Thrombocytopenia (ITP). J Thromb Haemost. 8(6):1372\u20131382","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1066_CR46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2141.2007.06807.x","volume":"139","author":"DJ Kuter","year":"2007","unstructured":"Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP (2007) Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol 139(3):351\u2013362","journal-title":"Br J Haematol"},{"issue":"22","key":"1066_CR47","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","volume":"357","author":"JB Bussel","year":"2007","unstructured":"Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B et al (2007) Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 357(22):2237\u20132247","journal-title":"N Engl J Med"},{"issue":"11","key":"1066_CR48","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood-2006-11-057968","volume":"109","author":"JM Jenkins","year":"2007","unstructured":"Jenkins JM, Williams D, Deng Y, Uhl J, Kitchen V, Collins D et al (2007) Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 109(11):4739\u20134741","journal-title":"Blood"},{"key":"1066_CR49","unstructured":"Revolade Summary of Product Characteristics Available at: http:\/\/www.ema.europa.eu\/humandocs\/PDFs\/EPAR\/revolade\/emea-combined-h1110en.pdf . Last accessed 26 May 2010"},{"issue":"9664","key":"1066_CR50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","volume":"373","author":"JB Bussel","year":"2009","unstructured":"Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L et al (2009) Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 373(9664):641\u2013648","journal-title":"Lancet"},{"issue":"S1","key":"1066_CR51","first-page":"949","volume":"93","author":"J Bussel","year":"2008","unstructured":"Bussel J, Cheng G, Saleh M, Meddeb B, Stone A, Mayer B et al (2008) Long-term safety and efficacy of oral eltrombopag for the treatment of idiopathic thrombocytopenic purpura (ITP). Haematologia 93(S1):949","journal-title":"Haematologia"},{"key":"1066_CR52","doi-asserted-by":"crossref","unstructured":"Cheng G, Saleh MN, Bussel JB, Marcher C, Vasey S, Mayer B et al (2008) Oral eltrombopag for the long-term treatment of patients with chronic idiopathic thrombocytopenic purpura: Results of a Phase III, Double- Blind, Placebo-Controlled Study (RAISE). ASH Annual Meeting Abstracts. 112(11):400","DOI":"10.1182\/blood.V112.11.400.400"},{"key":"1066_CR53","unstructured":"Mabthera Summary of Product Characteristics 2008. Available at: http:\/\/www.ema.europa.eu\/humandocs\/PDFs\/EPAR\/Mabthera\/emea-combined-h165en.pdf . last accessed: 1 Mar 2010"},{"issue":"1","key":"1066_CR54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","volume":"146","author":"DM Arnold","year":"2007","unstructured":"Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C et al (2007) Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 146(1):25\u201333","journal-title":"Ann Intern Med"},{"issue":"10","key":"1066_CR55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ajh.21512","volume":"84","author":"A Hasan","year":"2009","unstructured":"Hasan A, Michel M, Patel V, Stasi R, Cunningham-Rundles S, Leonard JP et al (2009) Repeated courses of rituximab in chronic ITP: three different regimens. Am J Hematol 84(10):661\u2013665","journal-title":"Am J Hematol"},{"issue":"14","key":"1066_CR56","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2009-07-229815","volume":"115","author":"F Zaja","year":"2010","unstructured":"Zaja F, Baccarani M, Mazza P, Bocchia M, Gugliotta L, Zaccaria A et al (2010) Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood 115(14):2755\u20132762","journal-title":"Blood"},{"issue":"20","key":"1066_CR57","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","volume":"113","author":"KR Carson","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF et al (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the research on adverse drug events and reports project. Blood 113(20):4834\u20134840","journal-title":"Blood"},{"key":"1066_CR58","unstructured":"US Food and Drug Administration. Information for Healthcare Professionals: Rituximab (marketed as Rituxan). Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm109106.htm . 2006"},{"issue":"12","key":"1066_CR59","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3324\/haematol.11709","volume":"92","author":"D Provan","year":"2007","unstructured":"Provan D, Butler T, Evangelista ML, Amadori S, Newland AC, Stasi R (2007) Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Haematologica 92(12):1695\u20131698","journal-title":"Haematologica"},{"issue":"6","key":"1066_CR60","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3324\/haematol.12206","volume":"93","author":"F Zaja","year":"2008","unstructured":"Zaja F, Battista ML, Pirrotta MT, Palmieri S, Montagna M, Vianelli N et al (2008) Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Haematologica 93(6):930\u2013933","journal-title":"Haematologica"},{"issue":"14","key":"1066_CR61","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2008-07-166439","volume":"113","author":"A Podolanczuk","year":"2009","unstructured":"Podolanczuk A, Lazarus AH, Crow AR, Grossbard E, Bussel JB (2009) Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. Blood 113(14):3154\u20133160","journal-title":"Blood"},{"issue":"2","key":"1066_CR62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14728214.13.2.237","volume":"13","author":"X Li","year":"2008","unstructured":"Li X, Hou M (2008) Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs 13(2):237\u2013254","journal-title":"Expert Opin Emerg Drugs"},{"issue":"7040","key":"1066_CR63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(58)90057-6","volume":"2","author":"EJ Watson-Williams","year":"1958","unstructured":"Watson-Williams EJ, Macpherson AI, Davidson S (1958) The treatment of idiopathic thrombocytopenic purpura; a review of 93 cases. Lancet 2(7040):221\u2013226","journal-title":"Lancet"},{"key":"1066_CR64","first-page":"119","volume":"48","author":"M Todorovic-Tirnanic","year":"2005","unstructured":"Todorovic-Tirnanic M, Obradovic V, Rolovic Z, Suvajdzic N, Elezovic I, Colovic M et al (2005) Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura. Glas Srpska akademija nauka i umetnosti 48:119\u2013135","journal-title":"Glas Srpska akademija nauka i umetnosti"},{"issue":"6617","key":"1066_CR65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bmj.296.6617.249-a","volume":"296","author":"AE Borne von dem","year":"1988","unstructured":"von dem Borne AE, Vos JJ, Pegels JG, Thomas LL, van der Lilie H (1988) High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia. Br Med J 296(6617):249\u2013250, Clinical research ed","journal-title":"Br Med J"},{"issue":"3","key":"1066_CR66","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0609.2004.00378.x","volume":"74","author":"I Kuku","year":"2005","unstructured":"Kuku I, Aydogdu I, Kaya E, Ali Erkurt M, Dikilitas M, Baydar M et al (2005) The early and long-term results of oral high-dose methylprednisolone treatment in adult patients with idiopathic thrombocytopenic purpura. Eur J Haematol 74(3):271\u2013272","journal-title":"Eur J Haematol"},{"issue":"9","key":"1066_CR67","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJMoa030254","volume":"349","author":"Y Cheng","year":"2003","unstructured":"Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP et al (2003) Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 349(9):831\u2013836","journal-title":"N Engl J Med"},{"issue":"6","key":"1066_CR68","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/bcmd.2000.0336","volume":"26","author":"R Stasi","year":"2000","unstructured":"Stasi R, Brunetti M, Pagano A, Stipa E, Masi M, Amadori S (2000) Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura. Blood Cells Mol Dis 26(6):582\u2013586","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"1066_CR69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00181824","volume":"251","author":"C Talar-Williams","year":"1994","unstructured":"Talar-Williams C, Sneller MC (1994) Complications of corticosteroid therapy. Eur Arch Otorhinolaryngol 251(3):131\u2013136","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"1066_CR70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","volume":"96","author":"KG Saag","year":"1994","unstructured":"Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B et al (1994) Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96(2):115\u2013123","journal-title":"Am J Med"},{"issue":"3","key":"1066_CR71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.20104","volume":"76","author":"LM Aledort","year":"2004","unstructured":"Aledort LM, Hayward CP, Chen MG, Nichol JL, Bussel J (2004) Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol 76(3):205\u2013213","journal-title":"Am J Hematol"},{"key":"1066_CR72","unstructured":"Amgen Inc. Nplate Prescribing information. Available at: http:\/\/www.nplatenexus.com\/pdfs\/misc\/nplate_pi.pdf . Last accessed 3 May 2010. 2008"},{"key":"1066_CR73","unstructured":"GlaxoSmithKline. Promacta Prescribing Information. http:\/\/us.gsk.com\/products\/assets\/us_promacta.pdf . Last accessed 3 May 2010. 2009"},{"key":"1066_CR74","doi-asserted-by":"crossref","unstructured":"Patel V, Mihatov N, Cooper N, Stasi R, Cunningham-Rundles S, Bussel JB (2006) Long Term Follow-Up of Patients with Immune Thrombocytopenic Purpura (ITP) Whose Initial Response to Rituximab Lasted a Minimum of 1\u00a0Year. ASH Annual Meeting Abstracts. 2006 November 16, 108(11):479","DOI":"10.1182\/blood.V108.11.479.479"},{"issue":"1","key":"1066_CR75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1054\/blre.2001.0186","volume":"16","author":"JR Adams","year":"2002","unstructured":"Adams JR, Nathan DP, Bennett CL (2002) Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy. Blood Rev 16(1):65\u201367","journal-title":"Blood Rev"},{"issue":"1","key":"1066_CR76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH07-08-0513","volume":"99","author":"R Stasi","year":"2008","unstructured":"Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S (2008) Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 99(1):4\u201313","journal-title":"Thromb Haemost"},{"key":"1066_CR77","unstructured":"Sandoglobulin Summary of Product Characteristics 2008. Available at: http:\/\/emc.medicines.org.uk\/medicine\/15934\/SPC\/Sandoglobulin+NF+Liquid%2c+120+mg+ml+solution+for+infusion\/ . Last accessed 08 Apr 09"},{"key":"1066_CR78","unstructured":"D-Gam Summary of Product Characteristics 2008. Available at: http:\/\/emc.medicines.org.uk\/medicine\/14735\/SPC\/D-GAM%2c+Solution+for+Injection+1%2c500+and+2%2c500iu+vials\/ . Last accessed: 21 Apr 2010"},{"key":"1066_CR79","unstructured":"WinRHO Summary of Product Characteristics. 2008. Available at: http:\/\/www.ecomm.baxter.com\/ecatalog\/loadResource.do?bid=39462 last accessed: 8 Apr 2009"},{"key":"1066_CR80","unstructured":"George JN, Buchanan G. ITP Support association platelet reprint series. Available at: http:\/\/www.itpsupport.org.uk\/american"},{"key":"1066_CR81","unstructured":"Risks and complications of surgery 2007. Available at: accessed at: http:\/\/generalmedicine.suite101.com\/article.cfm\/risks_and_complications_of_surgery ; last accessed: 13 May 2009"},{"issue":"9092","key":"1066_CR82","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(05)64276-6","volume":"350","author":"RF Schilling","year":"1997","unstructured":"Schilling RF (1997) Spherocytosis, splenectomy, strokes, and heat attacks. Lancet 350(9092):1677\u20131678","journal-title":"Lancet"},{"issue":"12","key":"1066_CR83","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/thx.2004.038083","volume":"60","author":"X Jais","year":"2005","unstructured":"Jais X, Ioos V, Jardim C, Sitbon O, Parent F, Hamid A et al (2005) Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 60(12):1031\u20131034","journal-title":"Thorax"},{"issue":"8029","key":"1066_CR84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(77)90132-5","volume":"2","author":"CD Robinette","year":"1977","unstructured":"Robinette CD, Fraumeni JF Jr (1977) Splenectomy and subsequent mortality in veterans of the 1939\u201345 war. Lancet 2(8029):127\u2013129","journal-title":"Lancet"},{"issue":"12","key":"1066_CR85","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1177\/0091270007306563","volume":"47","author":"Y Kumagai","year":"2007","unstructured":"Kumagai Y, Fujita T, Ozaki M, Sahashi K, Ohkura M, Ohtsu T et al (2007) Pharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: a randomized, placebo-controlled study. J Clin Pharmacol 47(12):1489\u20131497","journal-title":"J Clin Pharmacol"},{"key":"1066_CR86","unstructured":"Glaxosmithkline Ltd. Promacta FDA ODAC briefing document 2008"},{"issue":"12","key":"1066_CR87","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM196609222751202","volume":"275","author":"BA Bouroncle","year":"1966","unstructured":"Bouroncle BA, Doan CA (1966) Refractory idiopathic thrombocytopenic purpura treated with azathioprine. N Engl J Med 275(12):630\u2013635","journal-title":"N Engl J Med"},{"issue":"2","key":"1066_CR88","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.1990.tb02569.x","volume":"74","author":"I Quiquandon","year":"1990","unstructured":"Quiquandon I, Fenaux P, Caulier MT, Pagniez D, Huart JJ, Bauters F (1990) Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases. Br J Haematol 74(2):223\u2013228","journal-title":"Br J Haematol"},{"issue":"4","key":"1066_CR89","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.1967.03130170059006","volume":"202","author":"LN Sussman","year":"1967","unstructured":"Sussman LN (1967) Azathioprine in refractory idiopathic thrombocytopenic purpura. Jama 202(4):259\u2013263","journal-title":"Jama"},{"issue":"1","key":"1066_CR90","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(74)90745-1","volume":"56","author":"SC Finch","year":"1974","unstructured":"Finch SC, Castro O, Cooper M, Covey W, Erichson R, McPhedran P (1974) Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am J Med 56(1):4\u201312","journal-title":"Am J Med"},{"issue":"2","key":"1066_CR91","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood.V85.2.351.351","volume":"85","author":"A Reiner","year":"1995","unstructured":"Reiner A, Gernsheimer T, Slichter SJ (1995) Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood 85(2):351\u2013358","journal-title":"Blood"},{"issue":"5","key":"1066_CR92","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archinte.140.5.636","volume":"140","author":"T Srichaijul","year":"1980","unstructured":"Srichaijul T, Boonpucknavig S, Archararit N, Chaisiri-pumkeeree W (1980) Chronic immunologic thrombocytopenic purpura: results of cyclophosphamide therapy before splenectomy. Arch Intern Med 140(5):636\u2013638","journal-title":"Arch Intern Med"},{"issue":"1","key":"1066_CR93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.2830010111","volume":"1","author":"M Verlin","year":"1976","unstructured":"Verlin M, Laros RK Jr, Penner JA (1976) Treatment of refractory thrombocytopenic purpura with cyclophosphamine. Am J Hematol 1(1):97\u2013104","journal-title":"Am J Hematol"},{"issue":"1","key":"1066_CR94","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mpo.2950100110","volume":"10","author":"JR Krause","year":"1982","unstructured":"Krause JR (1982) Chronic idiopathic thrombocytopenic purpura (ITP:) development of acute non-lymphocytic leukemia subsequent to treatment with cyclophosphamide. Med Pediatr Oncol 10(1):61\u201365","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"1066_CR95","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2141.1996.4871026.x","volume":"93","author":"G Emilia","year":"1996","unstructured":"Emilia G, Messora C, Longo G, Bertesi M (1996) Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders. Br J Haematol 93(2):341\u2013344","journal-title":"Br J Haematol"},{"issue":"1","key":"1066_CR96","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2141.2001.02893.x","volume":"114","author":"MC Kappers-Klunne","year":"2001","unstructured":"Kappers-Klunne MC, van\u2019t Veer MB (2001) Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy. Br J Haematol 114(1):121\u2013125","journal-title":"Br J Haematol"},{"issue":"9","key":"1066_CR97","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjmed.2003.12.024","volume":"116","author":"F Maloisel","year":"2004","unstructured":"Maloisel F, Andres E, Zimmer J, Noel E, Zamfir A, Koumarianou A et al (2004) Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results. Am J Med 116(9):590\u2013594","journal-title":"Am J Med"},{"issue":"7","key":"1066_CR98","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/09537100802315110","volume":"19","author":"SM Vancine-Califani","year":"2008","unstructured":"Vancine-Califani SM, De Paula EV, Ozelo MC, Orsi FL, Fabri DR, Annichino-Bizzacchi JM (2008) Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. Platelets 19(7):489\u2013495","journal-title":"Platelets"},{"issue":"12","key":"1066_CR99","doi-asserted-by":"crossref","first-page":"e4031","DOI":"10.1371\/journal.pone.0004031","volume":"3","author":"CI Fanello","year":"2008","unstructured":"Fanello CI, Karema C, Avellino P, Bancone G, Uwimana A, Lee SJ et al (2008) High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency. PLoS ONE 3(12):e4031","journal-title":"PLoS ONE"},{"issue":"1","key":"1066_CR100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajh.20515","volume":"81","author":"D Provan","year":"2006","unstructured":"Provan D, Moss AJ, Newland AC, Bussel JB (2006) Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura. Am J Hematol 81(1):19\u201325","journal-title":"Am J Hematol"},{"issue":"5","key":"1066_CR101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2257.2006.00891.x","volume":"29","author":"AB Szczepanik","year":"2007","unstructured":"Szczepanik AB, Sikorska A, Slomkowski M, Konopka L (2007) The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients. Int J Lab Hematol 29(5):347\u2013351","journal-title":"Int J Lab Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-010-1066-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1066-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T09:24:11Z","timestamp":1685784251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-010-1066-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,15]]},"references-count":101,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1007\/s00277-010-1066-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,15]]}}}